Salim Essakali1,2, Dennis Carney1,3, David Westerman1,3, Peter Gambell1,3, John F Seymour1,3 and Alexander Dobrovic1,3
1Department of Pathology, Peter MacCallum Cancer Centre, St Andrews Place, Melbourne, Victoria 3002, Australia
2Universitaetsklinik Duesseldorf, Molekulare Pathologie, Moorenstr. 5, 40215 Duesseldorf, Germany
3Department of Pathology, University of Melbourne, Parkville, Victoria 3010, Australia
BMC Biotechnology 2008,
8:6. [Open Access]
Abstract
Background
High purity of tumour samples is a necessity for accurate genetic
and expression analysis and is usually achieved by positive selection
in chronic lymphocytic leukaemia (CLL).
Results
We adapted a bifunctional rosette-based antibody cocktail for
negative selection of B-cells for isolating CLL cells from peripheral
blood (PB). PB samples from CLL patients were split into aliquots. One
aliquot of each sample was enriched by density gradient centrifugation
(DGC), while the other aliquot of each sample was incubated with an
antibody cocktail for B-cell enrichment prior to DGC (RS+DGC). The
purity of CLL cells after DGC averaged 74.1% (range: 15.9 – 97.4%).
Using RS+DGC, the purity averaged 93.8% (range: 80.4 – 99.4%) with 23
of 29 (79%) samples showing CLL purities above 90%. RNA extracted from
enriched CLL cells was of appropriately high quality for microarray
analysis.
Conclusion
This study confirms the use of a bifunctional rosette-based antibody
cocktail as an effective method for the purification of CLL cells from
peripheral blood.